In this article, we discuss the 5 dividend stocks in Warren Buffett’s latest portfolio. If you want to read our detailed analysis of these stocks, go directly to the 10 Dividend Stocks in Warren Buffett’s Latest Portfolio.
5. Chevron Corporation (NYSE:CVX)
Number of Hedge Fund Holders: 50
Forward Dividend Yield: 4.57%
Chevron Corporation (NYSE:CVX) is an integrated oil and gas company headquartered in California. It recently spent $47 million bidding on a federal auction of oil leases in the US Gulf of Mexico. The oil firm was the biggest spender at the auction that saw other energy giants like Exxon in participation. Officials say $192 million was raised through the exercise.
Latest securities filings reveal that Berkshire Hathaway owned 28 million shares in Chevron Corporation (NYSE:CVX) at the end of the third quarter of 2021 worth $2.9 billion.
At the end of the second quarter of 2021, 50 hedge funds in the database of Insider Monkey held stakes worth $4.2 billion in Chevron Corporation (NYSE:CVX), up from 41 in the preceding quarter worth $4.8 billion.
In its Q1 2021 investor letter, ClearBridge Investments highlighted a few stocks and Chevron Corporation (NYSE:CVX) was one of them. Here is what the fund said:
“While reducing in health care and consumer staples, we increased our exposure to high-quality names in economically sensitive areas of the market. We added to low-cost, high-quality energy names, (including) Chevron. We are positive on the company’s strong balance sheets, competitive positions and exposure to an economic recovery.”
4. AbbVie Inc. (NYSE:ABBV)
Number of Hedge Fund Holders: 82
Forward Dividend Yield: 4.81%
AbbVie Inc. (NYSE:ABBV) develops and markets pharmaceutical products. Berkshire Hathaway owned 14 million shares in the company at the end of September 2021 worth $1.5 billion, representing 0.52% of the portfolio of the fund.
Morgan Stanley analyst David Risinger has an Overweight rating on AbbVie Inc. (NYSE:ABBV) stock with a price target of $124. In an investor note penned in early November, the analyst appreciated the strong quarterly earnings of the pharma firm.
At the end of the second quarter of 2021, 82 hedge funds in the database of Insider Monkey held stakes worth $5.3 billion in AbbVie Inc. (NYSE:ABBV), up from 72 in the preceding quarter worth $5.9 billion.
3. Bristol-Myers Squibb Company (NYSE:BMY)
Number of Hedge Fund Holders: 73
Forward Dividend Yield: 3.32%
Bristol-Myers Squibb Company (NYSE:BMY) is a New York-based pharmaceutical company. The firm posted earnings for the third quarter in late October, reporting earnings per share of $2.00, beating estimates by $0.08. The revenue over the period was $11.6 billion, smashing expectations by $100 million.
The hedge fund of billionaire Warren Buffett owned over 22 million shares of Bristol-Myers Squibb Company (NYSE:BMY) at the end of the third quarter of 2021 worth more than $1.3 billion, representing 0.44% of the portfolio of the fund.
At the end of the second quarter of 2021, 73 hedge funds in the database of Insider Monkey held stakes worth $4.5 billion in Bristol-Myers Squibb Company (NYSE:BMY), down from 81 in the preceding quarter worth $5.7 billion.
In its Q4 2020 investor letter, Wedgewood Partners, an asset management firm, highlighted a few stocks and Bristol-Myers Squibb Company (NYSE:BMY) was one of them. Here is what the fund said:
“Bristol-Myers Squibb recently reported accelerating sales as much of the medical services industry returned to work. The Company continues to expect double-digit earnings growth over the next few years, driven by existing drugs, in addition to a broad pipeline of new drugs and indications. While the market remains fixated on a couple of patent expirations that could occur over the next several years, we think this is well-known at this point, yet the market still undervalues a couple of key acquisitions the Company has made in the past few years, particularly Celgene, which was acquired for a song.”
2. STORE Capital Corporation (NYSE:STOR)
Number of Hedge Fund Holders: 13
Forward Dividend Yield: 4.55%
STORE Capital Corporation (NYSE: STOR) is a real estate investment trust that owns and manages single tenant properties. The firm has an impressive dividend history and recently declared a quarterly dividend of $0.385 per share, an increase of 7% from the previous dividend of $0.360.
According to regulatory filings, Berkshire Hathaway owned 24 million shares in STORE Capital Corporation (NYSE: STOR) at the end of September 2021 worth $782 million.
At the end of the second quarter of 2021, 13 hedge funds in the database of Insider Monkey held stakes worth $899 million in STORE Capital Corporation (NYSE: STOR), the same as in the previous quarter worth $886 million.
1. Johnson & Johnson (NYSE:JNJ)
Number of Hedge Fund Holders: 88
Forward Dividend Yield: 2.61%
Johnson & Johnson (NYSE:JNJ) makes and sells a range of healthcare products across the globe. Latest data shows that Berkshire Hathaway owned 327,100 shares of the company at the end of the third quarter of 2021 worth $52 million in value.
Johnson & Johnson (NYSE:JNJ) stock has been hit in recent days after rival Pfizer, which has developed an experimental version of the COVID-19 pill, announced that it would be allowing licensed generic drug makers to produce cheaper versions of the product.
At the end of the second quarter of 2021, 88 hedge funds in the database of Insider Monkey held stakes worth $7 billion in Johnson & Johnson (NYSE:JNJ), up from 81 in the previous quarter worth $6.9 billion.
You can also take a peek at 10 Best Stocks to Buy According to Warren Buffett and 11 Biotech Stocks Popular On Reddit.
